Get Rinvoq (Upadacitinib) Covered by Blue Cross Blue Shield in Virginia: Complete Guide to Prior Authorization and Appeals

Quick Answer: Getting Rinvoq Covered by Blue Cross Blue Shield in Virginia

Rinvoq (upadacitinib) requires prior authorization from Blue Cross Blue Shield Virginia, with step therapy typically requiring you to try TNF inhibitors first. The fastest path: 1) Have your doctor document failed therapies and submit a PA request through Anthem's provider portal, 2) Apply for AbbVie's copay assistance if commercially insured, and 3) Use a contracted specialty pharmacy. If denied, you have 180 days to appeal internally, then can request external review through Virginia's State Corporation Commission Bureau of Insurance within 120 days of final denial.

Start today: Ask your doctor to gather documentation of prior treatment failures and submit the PA request to Anthem Pharmacy at 1-833-267-3108.

Table of Contents

  1. Coverage Basics: Is Rinvoq Covered?
  2. Prior Authorization Process
  3. Step Therapy Requirements
  4. Specialty Pharmacy Requirements
  5. Timeline and Urgency
  6. Common Denial Reasons and Solutions
  7. Appeals Process in Virginia
  8. Cost-Saving Options
  9. When to Contact Virginia Regulators
  10. FAQ: Most Common Questions

Coverage Basics: Is Rinvoq Covered?

Blue Cross Blue Shield Virginia (Anthem) covers Rinvoq for FDA-approved conditions including rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis, and Crohn's disease. However, coverage requires prior authorization and typically places Rinvoq on the highest cost-sharing tier (Tier 5 specialty).

Coverage at a Glance

Requirement What It Means Where to Find It
Prior Authorization Doctor must get approval before prescribing Anthem Provider Portal
Step Therapy Must try preferred drugs first PA criteria documents
Specialty Pharmacy Must use contracted specialty pharmacy Anthem pharmacy network
Formulary Tier Tier 5 (highest cost-sharing) Plan formulary documents
Appeals Deadline 180 days for internal appeal Member handbook
Note: Requirements updated July 1, 2024, with stricter PA controls for specialty medications including JAK inhibitors.

Prior Authorization Process

Step-by-Step: Fastest Path to Approval

  1. Doctor Reviews Requirements (Day 1)
    • Check current Anthem PA criteria for Rinvoq
    • Gather documentation of diagnosis and prior treatments
    • Contact: Anthem Pharmacy 1-833-267-3108
  2. Submit PA Request (Days 1-3)
    • Use Availity Essentials portal or designated platform
    • Include: diagnosis with ICD-10, prior therapy history, clinical rationale
    • Timeline: Anthem processes within 24-48 hours after submission
  3. Specialty Pharmacy Setup (Days 2-5)
    • Prescription routed to contracted specialty pharmacy
    • Pharmacy coordinates with insurance and patient
    • Home delivery or clinic administration arranged
  4. Coverage Decision (Days 3-7)
    • Approval: Medication dispensed through specialty pharmacy
    • Denial: Appeal rights and next steps provided in writing
  5. Patient Copay Assistance (Ongoing)
    • Apply for AbbVie copay card if commercially insured
    • Complete enrollment in Rinvoq Complete support program

Required Documentation

Your doctor must provide:

  • Diagnosis: Specific condition with ICD-10 code
  • Prior Therapies: Names, doses, duration, and reasons for failure/discontinuation
  • Clinical Rationale: Why Rinvoq is medically necessary
  • Lab Results: Recent inflammatory markers, liver function tests
  • Treatment Goals: Expected outcomes and monitoring plan

Step Therapy Requirements

Blue Cross Blue Shield Virginia typically requires patients to try and fail preferred therapies before approving Rinvoq. This "step therapy" varies by condition:

Rheumatoid Arthritis

  1. First-line: Methotrexate or other conventional DMARDs
  2. Second-line: TNF inhibitors (adalimumab, etanercept, infliximab)
  3. Third-line: Rinvoq or other JAK inhibitors

Atopic Dermatitis

  1. First-line: Topical therapies, oral immunosuppressants
  2. Second-line: Dupixent (dupilumab)
  3. Third-line: Rinvoq

Step Therapy Exceptions

You may skip steps if you have:

  • Medical contraindications to preferred drugs
  • Previous intolerance with documented adverse reactions
  • Therapeutic drug monitoring showing inadequate levels despite optimal dosing
  • Clinical urgency requiring immediate treatment
Clinician Corner: For TNF inhibitor failures, include therapeutic drug monitoring (TDM) and anti-drug antibody (ADA) results when available. Low drug levels with low/no antibodies may require dose optimization before switching classes.

Specialty Pharmacy Requirements

Rinvoq must be dispensed through a specialty pharmacy—retail pharmacies cannot fill this prescription. Blue Cross Blue Shield Virginia contracts with specific specialty pharmacies for JAK inhibitors.

What This Means for You

  • Your prescription will be automatically transferred to a specialty pharmacy
  • The specialty pharmacy will contact you to coordinate delivery
  • Clinical support and insurance coordination included
  • Home delivery or clinic administration available

Common Specialty Pharmacy Partners

  • Accredo (Express Scripts)
  • CVS Specialty
  • Walgreens Specialty Pharmacy
  • Plan-specific contracted networks

Important: Prescriptions sent to regular pharmacies will be denied. Always verify your prescription is routed correctly.

Timeline and Urgency

Standard Timeline

  • PA Submission to Decision: 24-48 hours
  • Specialty Pharmacy Setup: 3-5 business days
  • First Dose: 7-10 days from PA approval

Expedited Process

For urgent medical needs:

  • Urgent PA Review: 72 hours
  • Emergency Access: Same-day approval possible
  • Criteria: Doctor must certify that delay could seriously jeopardize health

Contact Anthem at 1-833-267-3108 to request expedited review.

Common Denial Reasons and Solutions

Denial Reason How to Overturn Required Documentation
Insufficient step therapy Document failed trials Therapy names, dates, outcomes, adverse reactions
Missing clinical information Submit complete medical records Diagnosis confirmation, lab results, clinical notes
Non-formulary status Request formulary exception Medical necessity letter, prior therapy failures
Quantity limits exceeded Justify dosing regimen FDA labeling, clinical guidelines, weight-based calculations
Safety concerns Address contraindications Recent labs, screening results, risk mitigation plan

Medical Necessity Letter Checklist

Your doctor should include:

  • Problem Statement: Current disease activity and impact
  • Prior Treatments: Specific drugs tried, duration, outcomes
  • Clinical Rationale: Why Rinvoq is appropriate now
  • Guideline Support: ACR, AAD, or other society recommendations
  • Monitoring Plan: How safety will be managed

Appeals Process in Virginia

If your Rinvoq request is denied, Virginia law provides multiple appeal levels:

Internal Appeal (Required First Step)

  • Deadline: 180 days from denial notice
  • Timeline: Anthem must respond within 30 days (pre-service) or 60 days (post-service)
  • Urgent Appeals: 72-hour response for urgent medical needs
  • How to File: Call member services or submit written appeal

External Review (Independent Review)

  • When Available: After internal appeal denial or no response
  • Deadline: 120 days from final internal denial
  • Process: Virginia State Corporation Commission Bureau of Insurance assigns independent reviewer
  • Timeline: 45 days for standard review, 72 hours for urgent
  • Cost: Free to consumers

Virginia External Review Process

  1. Contact SCC Bureau of Insurance
    • Phone: 1-877-310-6560
    • Complete Form 216-A (External Review Request)
    • Submit supporting documentation
  2. Eligibility Review
    • Must be Virginia-issued plan or opted-in self-funded plan
    • Denial based on medical necessity or experimental treatment
    • Internal appeals exhausted (unless urgent)
  3. Independent Review Organization (IRO) Assignment
    • Random assignment from approved roster
    • Conflict-of-interest screening
    • Clinical expertise matching
  4. Final Decision
    • Binding on insurer and patient
    • If overturned, coverage within 1-3 days
    • If upheld, consider legal consultation
From Our Advocates: "We've seen Virginia external reviews succeed when patients provide comprehensive documentation showing Rinvoq meets FDA-approved criteria and prior therapies genuinely failed. The key is organizing your medical history chronologically and highlighting specific adverse reactions or lack of efficacy with previous treatments."

Cost-Saving Options

Manufacturer Support Programs

AbbVie Complete Copay Card

  • Eligibility: Commercial insurance (not Medicare, Medicaid, VA, Tricare)
  • Savings: Significant reduction in out-of-pocket costs
  • How to Apply: RINVOQSavingsCard.com or 1-800-2RINVOQ
  • Additional Support: Care coordinators, injection training, adherence support

Foundation and Grant Programs

  • Independent foundations may offer assistance for those ineligible for manufacturer support
  • State-specific programs in Virginia for medication assistance
  • Verify eligibility as programs change frequently

Insurance Cost-Sharing

Rinvoq typically falls under:

  • Tier 5 Specialty: 30-50% coinsurance after deductible
  • Deductible: Must be met before coverage begins
  • Out-of-pocket maximum: Annual limit on your costs

When to Contact Virginia Regulators

Contact the Virginia State Corporation Commission if:

  • Your insurer violates appeal timelines
  • You suspect discriminatory coverage policies
  • You need guidance on external review process
  • Your employer's self-funded plan opts out of state protections

Virginia SCC Bureau of Insurance

  • Phone: 1-877-310-6560
  • Website: scc.virginia.gov
  • Services: External review, consumer complaints, insurance guidance

Virginia Managed Care Ombudsman

  • Part of SCC Consumer Services
  • Specializes in HMO and managed care issues
  • Can help resolve issues informally

FAQ: Most Common Questions

Q: How long does Blue Cross Blue Shield PA take in Virginia? A: Standard PA requests are processed within 24-48 hours. Urgent requests receive 72-hour turnaround.

Q: What if Rinvoq is non-formulary on my plan? A: Request a formulary exception by documenting medical necessity and prior therapy failures. Your doctor submits this request along with the PA.

Q: Can I request an expedited appeal? A: Yes, if your doctor certifies that waiting could seriously jeopardize your health. Expedited appeals receive 72-hour decisions.

Q: Does step therapy apply if I failed treatments in another state? A: Yes, documented treatment failures from any location count toward step therapy requirements. Ensure your Virginia doctor has complete records.

Q: What happens if my appeal is denied? A: You can request external review through Virginia's Bureau of Insurance within 120 days. This independent review is binding on your insurer.

Q: Are there alternatives if Rinvoq is denied? A: Other JAK inhibitors (Xeljanz, Olumiant) or different biologic classes (IL-17, IL-23 inhibitors) may be options depending on your condition.

Q: How do I find a contracted specialty pharmacy? A: Contact Anthem member services or check your online portal for the specialty pharmacy network directory.

Q: What if I'm on Medicare or Medicaid? A: Medicare Part D and Medicaid have separate PA processes. Manufacturer copay assistance is not available for government insurance programs.


How Counterforce Health Can Help

Counterforce Health specializes in turning insurance denials into successful appeals by creating targeted, evidence-backed responses. Our platform analyzes denial letters, identifies the specific reasons for rejection, and drafts point-by-point rebuttals using the right medical evidence—FDA labeling, peer-reviewed studies, and specialty guidelines—aligned to your plan's own coverage rules.

For complex cases like Rinvoq approvals, where step therapy requirements and safety documentation can make or break your appeal, having expert support can significantly improve your chances of success. We help patients, clinicians, and specialty pharmacies navigate the prior authorization maze with cleaner submissions that reduce back-and-forth delays.

Sources & Further Reading


Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult with your healthcare provider and insurance company for the most current coverage policies and medical guidance specific to your situation. Coverage policies and requirements may change without notice.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.